Invention Grant
- Patent Title: Substituted quinoxalines as B-raf kinase inhibitors
-
Application No.: US14442084Application Date: 2013-11-12
-
Publication No.: US09725421B2Publication Date: 2017-08-08
- Inventor: Xiangping Qian , Yong-liang Zhu
- Applicant: NEUPHARMA, INC.
- Applicant Address: US CA Foster City
- Assignee: NEUPHARMA, INC.
- Current Assignee: NEUPHARMA, INC.
- Current Assignee Address: US CA Foster City
- Agency: Wilson, Sonsini, Goodrich & Rosati
- International Application: PCT/US2013/069699 WO 20131112
- International Announcement: WO2014/075077 WO 20140515
- Main IPC: A61K31/498
- IPC: A61K31/498 ; C07D241/42 ; C07D241/44 ; A61K31/5377 ; C07D403/12 ; C07D401/04 ; C07D413/12 ; A61K45/06
Abstract:
Described herein are kinase inhibitors represented by Formula I: and pharmaceutical compositions thereof, for use in the treatment of cancer.
Public/Granted literature
- US20160009663A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Public/Granted day:2016-01-14
Information query
IPC分类:
